Page last updated: 2024-08-26

vitamin b 6 and Adamantiades-Behcet Disease

vitamin b 6 has been researched along with Adamantiades-Behcet Disease in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akdağ-Köse, A; Bekpinar, S; Genç, S; Göğüş, F; Koçak, H; Unlüçerçi, Y	1
Danese, S; Gasbarrini, A; Gasbarrini, G; Papa, A	1

Trials

1 trial(s) available for vitamin b 6 and Adamantiades-Behcet Disease

Article	Year
The evaluation of C-reactive protein, homocysteine and vitamin B6 concentrations in Behçet and rheumatoid arthritis disease. Clinica chimica acta; international journal of clinical chemistry, 2003, Volume: 329, Issue:1-2 Topics: Adult; Arthritis, Rheumatoid; Behcet Syndrome; C-Reactive Protein; Female; Homocysteine; Humans; Male; Pyridoxal Phosphate; Vitamin B 6	2003

Other Studies

1 other study(ies) available for vitamin b 6 and Adamantiades-Behcet Disease

Article	Year
Assessment of prothrombotic risk in patients with Behçet's disease should include homocysteine plasma levels. The Journal of rheumatology, 2001, Volume: 28, Issue:12 Topics: Behcet Syndrome; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Risk Factors; Thromboembolism; Vitamin B 12; Vitamin B 6	2001

Article

Year

Assessment of prothrombotic risk in patients with Behçet's disease should include homocysteine plasma levels.

The Journal of rheumatology, 2001, Volume: 28, Issue:12

Topics: Behcet Syndrome; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Risk Factors; Thromboembolism; Vitamin B 12; Vitamin B 6

2001